Lupin Limited (LUPIN.NS)
INR 1937.2
(0.16%)
INR 1937.2
(0.16%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 196.56 Billion INR | 20.81% |
| 2022 | 162.69 Billion INR | 0.48% |
| 2021 | 161.92 Billion INR | 8.48% |
| 2020 | 149.26 Billion INR | -1.43% |
| 2019 | 151.42 Billion INR | -7.49% |
| 2018 | 163.69 Billion INR | 5.25% |
| 2017 | 155.52 Billion INR | -8.48% |
| 2016 | 169.92 Billion INR | 24.2% |
| 2015 | 136.81 Billion INR | 8.7% |
| 2014 | 125.85 Billion INR | 13.5% |
| 2013 | 110.88 Billion INR | 17.34% |
| 2012 | 94.49 Billion INR | 33.42% |
| 2011 | 70.82 Billion INR | 24.11% |
| 2010 | 57.06 Billion INR | 20.38% |
| 2009 | 47.4 Billion INR | 25.55% |
| 2008 | 37.75 Billion INR | 39.52% |
| 2007 | 27.06 Billion INR | 34.4% |
| 2006 | 20.13 Billion INR | 18.77% |
| 2005 | 16.95 Billion INR | 34.43% |
| 2004 | 12.61 Billion INR | 3.78% |
| 2003 | 12.15 Billion INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 56 Billion INR | 14.41% |
| 2023 Q1 | 47.42 Billion INR | 9.51% |
| 2023 Q4 | 48.95 Billion INR | -3.64% |
| 2023 FY | 196.56 Billion INR | 20.81% |
| 2023 Q3 | 50.79 Billion INR | 2.85% |
| 2023 Q2 | 49.39 Billion INR | 4.16% |
| 2022 Q3 | 42.44 Billion INR | 3.75% |
| 2022 FY | 162.69 Billion INR | 0.48% |
| 2022 Q1 | 36.03 Billion INR | -6.74% |
| 2022 Q2 | 40.91 Billion INR | 13.52% |
| 2022 Q4 | 43.3 Billion INR | 2.02% |
| 2021 FY | 161.92 Billion INR | 8.48% |
| 2021 Q3 | 40.87 Billion INR | 2.1% |
| 2021 Q1 | 42.37 Billion INR | 12.72% |
| 2021 Q4 | 38.64 Billion INR | -5.46% |
| 2021 Q2 | 40.03 Billion INR | -5.52% |
| 2020 Q1 | 34.68 Billion INR | -8.5% |
| 2020 Q2 | 37.81 Billion INR | 9.03% |
| 2020 Q3 | 39.17 Billion INR | 3.58% |
| 2020 FY | 149.26 Billion INR | -1.43% |
| 2020 Q4 | 37.59 Billion INR | -4.03% |
| 2019 Q3 | 37.16 Billion INR | -13.52% |
| 2019 Q4 | 37.91 Billion INR | 2.02% |
| 2019 Q2 | 42.96 Billion INR | -1.35% |
| 2019 Q1 | 43.55 Billion INR | 0.69% |
| 2019 FY | 151.42 Billion INR | -7.49% |
| 2018 Q3 | 43.77 Billion INR | 12.52% |
| 2018 FY | 163.69 Billion INR | 5.25% |
| 2018 Q4 | 43.25 Billion INR | -1.19% |
| 2018 Q1 | 37.74 Billion INR | -6.43% |
| 2018 Q2 | 38.9 Billion INR | 3.08% |
| 2017 Q4 | 40.33 Billion INR | 3.42% |
| 2017 Q3 | 39 Billion INR | -1.31% |
| 2017 Q2 | 39.51 Billion INR | 2.13% |
| 2017 Q1 | 38.69 Billion INR | -9.02% |
| 2017 FY | 155.52 Billion INR | -8.48% |
| 2016 Q1 | 44.39 Billion INR | 5.77% |
| 2016 Q4 | 42.53 Billion INR | -5.12% |
| 2016 Q3 | 44.82 Billion INR | 4.48% |
| 2016 Q2 | 42.9 Billion INR | -3.35% |
| 2016 FY | 169.92 Billion INR | 24.2% |
| 2015 Q1 | 31.5 Billion INR | 8.85% |
| 2015 Q2 | 33.21 Billion INR | 5.43% |
| 2015 FY | 136.81 Billion INR | 8.7% |
| 2015 Q3 | 35.55 Billion INR | 7.06% |
| 2015 Q4 | 41.97 Billion INR | 18.04% |
| 2014 Q1 | 33.4 Billion INR | 14.31% |
| 2014 FY | 125.85 Billion INR | 13.5% |
| 2014 Q2 | 31.73 Billion INR | -5.01% |
| 2014 Q4 | 28.94 Billion INR | -8.92% |
| 2014 Q3 | 31.77 Billion INR | 0.13% |
| 2013 Q4 | 29.22 Billion INR | -3.29% |
| 2013 Q3 | 30.21 Billion INR | 13.27% |
| 2013 Q2 | 26.67 Billion INR | 7.74% |
| 2013 Q1 | 24.76 Billion INR | -1.96% |
| 2013 FY | 110.88 Billion INR | 17.34% |
| 2012 Q3 | 24.65 Billion INR | 7.18% |
| 2012 FY | 94.49 Billion INR | 33.42% |
| 2012 Q4 | 25.25 Billion INR | 2.43% |
| 2012 Q1 | 22.53 Billion INR | 12.33% |
| 2012 Q2 | 23 Billion INR | 2.08% |
| 2011 Q4 | 20.06 Billion INR | 11.98% |
| 2011 FY | 70.82 Billion INR | 24.11% |
| 2011 Q3 | 17.91 Billion INR | 0.0% |
| 2010 FY | 57.06 Billion INR | 20.38% |
| 2009 FY | 47.4 Billion INR | 25.55% |
| 2008 FY | 37.75 Billion INR | 39.52% |
| 2007 FY | 27.06 Billion INR | 34.4% |
| 2006 FY | 20.13 Billion INR | 18.77% |
| 2005 FY | 16.95 Billion INR | 34.43% |
| 2004 FY | 12.61 Billion INR | 3.78% |
| 2003 FY | 12.15 Billion INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Hester Biosciences Limited | 3.04 Billion INR | -6354.309% |
| Albert David Limited | 3.62 Billion INR | -5323.012% |
| Alembic Limited | 1.57 Billion INR | -12381.381% |
| Alkem Laboratories Limited | 126.67 Billion INR | -55.17% |
| Alembic Pharmaceuticals Limited | 61.12 Billion INR | -221.597% |
| Bafna Pharmaceuticals Limited | 1.52 Billion INR | -12792.303% |
| Bajaj HealthCare Limited | 4.73 Billion INR | -4052.006% |
| FDC Limited | 19.42 Billion INR | -911.678% |
| Glenmark Life Sciences Limited | 22.83 Billion INR | -760.907% |
| Gufic Biosciences Limited | 8.06 Billion INR | -2336.739% |
| Hikal Limited | 17.84 Billion INR | -1001.442% |
| Ind-Swift Laboratories Limited | 12.8 Billion INR | -1434.573% |
| Ind-Swift Limited | 5.02 Billion INR | -3811.958% |
| Innova Captab Limited | 10.81 Billion INR | -1717.835% |
| Jagsonpal Pharmaceuticals Limited | 2.08 Billion INR | -9318.376% |
| Jubilant Pharmova Limited | 67.02 Billion INR | -193.251% |
| Kilitch Drugs (India) Limited | 1.54 Billion INR | -12633.058% |
| Laurus Labs Limited | 50.01 Billion INR | -292.985% |
| Lincoln Pharmaceuticals Limited | 5.8 Billion INR | -3285.816% |
| Mangalam Drugs & Organics Limited | 3.67 Billion INR | -5250.796% |
| Medico Remedies Limited | 1.44 Billion INR | -13463.514% |
| Morepen Laboratories Limited | 17.01 Billion INR | -1054.965% |
| Nectar Lifesciences Limited | 16.84 Billion INR | -1066.845% |
| Orchid Pharma Limited | 8.19 Billion INR | -2298.963% |
| Procter & Gamble Health Limited | 11.51 Billion INR | -1607.376% |
| RPG Life Sciences Limited | 5.82 Billion INR | -3277.088% |
| Solara Active Pharma Sciences Limited | 12.38 Billion INR | -1487.25% |
| Sun Pharmaceutical Industries Limited | 484.96 Billion INR | 59.469% |
| Suven Pharmaceuticals Limited | 10.51 Billion INR | -1769.622% |
| Themis Medicare Limited | 3.81 Billion INR | -5048.863% |
| Unichem Laboratories Limited | 16.57 Billion INR | -1085.963% |
| Vaishali Pharma Limited | 862.79 Million INR | -22682.114% |
| Venus Remedies Limited | 5.91 Billion INR | -3223.418% |
| Wanbury Limited | 5.75 Billion INR | -3314.635% |
| Windlas Biotech Limited | 6.3 Billion INR | -3015.327% |
| ZIM Laboratories Limited | 3.67 Billion INR | -5248.417% |
| Ipca Laboratories Limited | 77.05 Billion INR | -155.082% |
| Aarti Drugs Limited | 25.28 Billion INR | -677.368% |
| Aarti Pharmalabs Limited | 18.15 Billion INR | -982.693% |
| Biofil Chemicals and Pharmaceuticals Limited | 400.35 Million INR | -48997.521% |
| Brooks Laboratories Limited | 794.86 Million INR | -24629.28% |
| Eris Lifesciences Limited | 20.09 Billion INR | -878.344% |
| IOL Chemicals and Pharmaceuticals Limited | 21.32 Billion INR | -821.626% |
| Sigachi Industries Limited | 3.98 Billion INR | -4826.943% |
| Sakar Healthcare Limited | 1.54 Billion INR | -12650.006% |
| Aurobindo Pharma Limited | 290.01 Billion INR | 32.224% |
| Divi's Laboratories Limited | 78.45 Billion INR | -150.559% |
| AstraZeneca Pharma India Limited | 12.95 Billion INR | -1417.243% |
| Mankind Pharma Limited | 103.34 Billion INR | -90.196% |
| Sequent Scientific Limited | 13.69 Billion INR | -1335.051% |
| Neuland Laboratories Limited | 15.58 Billion INR | -1161.169% |
| J. B. Chemicals & Pharmaceuticals Limited | 34.47 Billion INR | -470.134% |
| Glenmark Pharmaceuticals Limited | 118.13 Billion INR | -66.394% |
| Zydus Lifesciences Limited | 190.21 Billion INR | -3.337% |
| Amrutanjan Health Care Limited | 4.21 Billion INR | -4566.409% |
| Wockhardt Limited | 27.89 Billion INR | -604.781% |
| Bal Pharma Limited | 3.39 Billion INR | -5694.577% |
| Dr. Reddy's Laboratories Limited | 279.16 Billion INR | 29.589% |
| Bliss GVS Pharma Limited | 7.7 Billion INR | -2451.96% |
| Par Drugs and Chemicals Limited | 956.4 Million INR | -20452.34% |
| Caplin Point Laboratories Limited | 16.76 Billion INR | -1072.267% |
| Shilpa Medicare Limited | 11.53 Billion INR | -1604.642% |
| Valiant Laboratories Limited | 1.82 Billion INR | -10696.794% |
| Ajanta Pharma Limited | 42.08 Billion INR | -367.04% |
| Aarey Drugs & Pharmaceuticals Limited | 3.95 Billion INR | -4868.516% |
| Granules India Limited | 45.06 Billion INR | -336.19% |
| Medicamen Biotech Limited | 1.79 Billion INR | -10862.443% |
| Syncom Formulations (India) Limited | 2.59 Billion INR | -7482.177% |
| Piramal Enterprises Limited | 60.33 Billion INR | -225.774% |
| Torrent Pharmaceuticals Limited | 106.05 Billion INR | -85.342% |
| NATCO Pharma Limited | 40.02 Billion INR | -391.163% |
| Suven Life Sciences Limited | 116.92 Million INR | -168004.918% |
| Krebs Biochemicals & Industries Limited | 504.21 Million INR | -38884.045% |
| Strides Pharma Science Limited | 40.51 Billion INR | -385.207% |
| Indoco Remedies Limited | 18.17 Billion INR | -981.629% |
| Alpa Laboratories Limited | 1.08 Billion INR | -17976.624% |
| Lasa Supergenerics Limited | 1.04 Billion INR | -18739.642% |
| Sun Pharma Advanced Research Company Limited | 755.45 Million INR | -25919.276% |